We are pleased to announce the Abcam has won an award for the ‘Best Careers Website’ at the In-house Recruitment Awards. The award recognises a careers website that clearly reflects the company’s brand ethos, whilst providing an engaging user experience that assists the applicant throughout the hiring process. The judges said: “In an increasingly online […]
Abcam’s multiplex immunoassays combine unique Firefly® hydrogel technology with Abcam’s high-performance antibodies to simultaneously measure up to 75 different proteins in a mere 12.5 µL of sample. With sensitivity below 1 pg/mL, the assay can provide rapid multiplex data within hours1, even in complex matrices with low target concentrations. Unlike many other multiplex assays which […]
Matched antibody pair kits provide assays with reproducible, sensitive and high-throughput detection Cambridge, UK, 12 April 2016: Abcam plc, a global leader in the supply of life science research tools, today announced the launch of a suite of immunoassay products based on its recombinant, monoclonal antibody pairs, as part of its commitment to deliver quality […]
Abcam’s founder has won the CiteAb lifetime achievement award. This award recognises and promotes an individual who has made an outstanding contribution to the research antibody industry. Jonathan founded Abcam after becoming frustrated by the lack of high quality antibodies available. He wanted to provide researchers with the products and services that he needed while […]
Cambridge, UK, 12 November 2015: Abcam plc, a global leader in the supply of life science research tools, announced today the launch of its direct service to Singapore, as part of a global commitment to support local researchers’ needs. The new Singapore service will provide direct technical support and customer services, expanding Abcam’s presence in […]
AxioMx provides a unique, cost-effective, and proprietary platform to produce recombinant monoclonal antibodies complementing Abcam’s existing innovative production capabilities This in vitro technology will enable Abcam to offer new tools to existing and new customers working in technically challenging areas such as infectious disease, toxins, nucleotides, and membrane bound proteins AxioMx is already providing life […]
Clone 28-8 provides researchers with knockout validated antibody to critical checkpoint inhibitor Cambridge, UK, 06 October 2015: Abcam plc, a global leader in the supply of life sciences research tools, today announced the launch of its anti-PD-L1 primary antibody (clone 28-8). Produced using Abcam’s RabMAb® recombinant monoclonal antibody technology, the clone offers highly specific and […]
Cambridge UK, 9 September 2015 – Abcam plc, a global leader in the supply of life science research tools, today announced an industry-changing antibody validation initiative to address the critical need for antibodies with a higher target specificity. A recent article by Nature identified that around 50% of budgets for protein-binding reagents are wasted globally […]
Cambridge, UK, June 29, 2015:Abcam plc., a global leader in the supply of life science research tools, announces that it has appointed Suzanne Smith in the new role of Chief Legal Officer and Company Secretary, based at Abcam’s headquarters in Cambridge, UK, effective from 6 July 2015. Accordingly, Jeff Iliffe will resign from the role […]
Assays use innovative Firefly™ particle technology to enhance miRNA research Cambridge UK, June 10, 2015: Abcam plc, a global leader in the supply of life science research tools, announced today the launch of a range of multiplex miRNA profiling assays for high-throughput validation of miRNA biomarkers, based on Abcam’s new Firefly™ particle technology. The new […]
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
Website by FisherPaul